Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients

Nakajima, Y; Mizumachi, K; Shimonishi, N; Furukawa, S; Yada, K; Ogiwara, K; Takeyama, M; Shima, M; Nogami, K

Nakajima, Y (通讯作者)，Nara Med Univ, Dept Pediat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.;Nakajima, Y (通讯作者)，Nara Med Univ, Adv Med Sci Thrombosis & Hemostasis, Kashihara, Nara, Japan.

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022; 115 (4): 489

Abstract

Emicizumab reduces bleeding events in patients with severe hemophilia A (HA). The coagulation potential of emicizumab at a clinical dose appears to co......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索